Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $85.88 Analyst target: $70.33 Upside: -18.11%
CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.
See the full interactive analysis & chart →Informational only — not investment advice.